1 year return (CAGR)
8.31%
DiaMedica Therapeutics Inc Exchange (NASDAQ, USD)
DMAC
7.94
-0.22 (-2.83%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
35.93%
5 year return (CAGR)
14.33%
10 year return (CAGR)
-9.51%
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
407.68M
Price/Sales
-
Ent value
409.21M
Price/Book
10.63
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
-2.31%
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 7.70 |
| Daily high | 7.74 |
| Daily low | 7.34 |
| Daily Volume | 174K |
| All-time high | 44.18 |
| 1y analyst estimate | 15.50 |
| Beta | 0.97 |
| EPS (TTM) | -0.70 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | 31 Mar 2026 |
Downside potential
Loading...
Downside potential data
| DMAC | S&P500 | |
| Current price drop from All-time high | -82.03% | -0.84% |
| Highest price drop | -98.16% | -56.47% |
| Date of highest drop | 5 Dec 2014 | 9 Mar 2009 |
| Avg drop from high | -87.69% | -10.68% |
| Avg time to new high | 510 days | 12 days |
| Max time to new high | 2546 days | 1805 days |
News
